High resolution crystal structures of piscine transthyretin reveal different binding modes for triiodothyronine and thyroxine by Eneqvist, Therese et al.
Sauer-Eriksson
Santos, Deborah M. Power and A. Elisabeth
Karlsson, Shenghua Huang, Cecília R. A. 
Therese Eneqvist, Erik Lundberg, Anders
  
Thyroxine
Binding Modes for Triiodothyronine and
Piscine Transthyretin Reveal Different 
High Resolution Crystal Structures of
Protein Structure and Folding:
doi: 10.1074/jbc.M313553200 originally published online April 13, 2004
2004, 279:26411-26416.J. Biol. Chem. 
  
 10.1074/jbc.M313553200Access the most updated version of this article at doi: 
  
.JBC Affinity SitesFind articles, minireviews, Reflections and Classics on similar topics on the 
 Alerts: 
  
 When a correction for this article is posted•  
 When this article is cited•  
 to choose from all of JBC's e-mail alertsClick here
  
 http://www.jbc.org/content/279/25/26411.full.html#ref-list-1
This article cites 52 references, 8 of which can be accessed free at




















High Resolution Crystal Structures of Piscine Transthyretin Reveal
Different Binding Modes for Triiodothyronine and Thyroxine*
Received for publication, December 11, 2003, and in revised form, March 16, 2004
Published, JBC Papers in Press, April 13, 2004, DOI 10.1074/jbc.M313553200
Therese Eneqvist‡§, Erik Lundberg‡, Anders Karlsson‡, Shenghua Huang‡, Cecı´lia R. A. Santos¶,
Deborah M. Power¶, and A. Elisabeth Sauer-Eriksson‡
From the ‡Umeå Centre for Molecular Pathogenesis, Umeå University, SE-901 87 Umeå, Sweden and the ¶Centro de
Ciencias de MAR, Universidade do Algarve, Campus de Gambelas, 8005–139 Faro, Portugal
Transthyretin (TTR) is an extracellular transport pro-
tein involved in the distribution of thyroid hormones
and vitamin A. So far, TTR has only been found in ver-
tebrates, of which piscine TTR displays the lowest se-
quence identity with human TTR (47%). Human and
piscine TTR bind both thyroid hormones 3,5,3-triiodo-
L-thyronine (T3) and 3,5,3,5-tetraiodo-L-thyronine (thy-
roxine, T4). Human TTR has higher affinity for T4 than
T3, whereas the reverse holds for piscine TTR. X-ray
structures of Sparus aurata (sea bream) TTR have been
determined as the apo-protein at 1.75 Å resolution and
bound to ligands T3 and T4, both at 1.9 Å resolution. The
apo structure is similar to human TTR with structural
changes only at -strand D. This strand forms an ex-
tended loop conformation similar to the one in chicken
TTR. The piscine TTRT4 complex shows the T4-binding
site to be similar but not identical to human TTR,
whereas the TTRT3 complex shows the I3 halogen sit-
uated at the site normally occupied by the hydroxyl
group of T4. The significantly wider entrance of the hor-
mone-binding channel in sea bream TTR, in combina-
tion with its narrower cavity, provides a structural ex-
planation for the different binding affinities of human
and piscine TTR to T3 and T4.
Transthyretin (TTR)1 is one of three proteins in the extra-
cellular fluids of vertebrates responsible for the distribution of
the two thyroid hormones 3,5,3-triiodo-L-thyronine (T3) and
3,5,3,5-tetraiodo-L-thyronine (thyroxine, T4) (1). TTR also
transports vitamin A by forming a complex with retinol-bind-
ing protein (for reviews, see Refs. 2 and 3). Although members
of a related protein family were identified in lower species (4),
TTR homologues have only been found in vertebrates and share
high sequence identity. Of these orders, piscine TTR has the
lowest sequence identity compared with human TTR. The first
complete cDNA sequence of a piscine transthyretin homologue
was isolated from sea bream (Sparus aurata) and has 47%
sequence identity with human TTR (5–7). Interestingly, piscine
TTR displays a higher affinity for T3 than T4 (7, 8), as do the
amphibian and avian TTRs. This is in contrast to the marsu-
pial and mammalian proteins, which have higher affinity for T4
(9, 10). In birds, marsupials, and mammals, TTR is expressed
both in the liver and choroid plexus of the brain, whereas in
reptiles it is expressed only in the choroid plexus. In fish or
amphibians the main production is in the liver (2, 3, 11). This
suggests that the binding affinities of TTR changed during
evolution. In mammalian TTR, transport of T4 is preferred
across the blood-brain barrier, where T4 is converted to the
biologically more active T3 hormone (12). This evolution may
correlate with the evolution of deiodinases, which generate T3
from T4 in a tissue-specific action (12, 13).
The three-dimensional structure of transthyretin is a ho-
motetramer with a central hydrophobic channel in which the
two hormone-binding sites are situated (14–17). The two reti-
nol-binding protein-binding sites have also been structurally
characterized and are situated on the surface of the molecule
(18, 19). Previously determined structures of chicken, rat, and
human TTR are very similar, with the exception of the -helical
region, which is somewhat different in the avian structure
compared with the mammalian proteins (20, 21).
Single point mutations in human transthyretin give rise to
familial amyloidotic polyneuropathy (FAP), a hereditary form
of amyloidosis associated with fibrillar TTR deposits in the
peripheral nerves, kidney, spleen, heart, and eye (22–24). More
than 70 different amino acid substitutions related to FAP have
been identified so far (25), two of which are present in the sea
bream TTR sequence, namely V30L and I84S (26). Structural
changes within the TTR molecule underlie the formation of
TTR amyloid fibrils (27, 28). To elucidate the mechanism be-
hind TTR amyloidosis, structural analyses of TTR from other
organisms can provide valuable information. This study de-
scribes three crystal structures: apo sea bream TTR at 1.75 Å
resolution; in complex with T3 at 1.9 Å; and in complex with T4,
also at 1.9 Å. The structures are compared with the human, rat,
and chicken homologues, and molecular details behind thyroid-
hormone binding are discussed.
MATERIALS AND METHODS
Cloning of Sea Bream TTR—A construct corresponding to the ma-
ture sea bream TTR, predicted by SignalP v1.1 (29), was amplified from
the full-length cDNA located in a PA20H vector (7) using the forward
primer 5-TTT TTC ATG ACC CCC ACC CCC ACG-3 (Interactiva
Virtual Laboratory). This primer introduces the N-terminal methionine
and a BspH1 cleavage site, which changes the first Ala-19 codon GCC
to ACC that encodes Thr. The reverse primer 5-TTT CGA GCT CAC
TCG TGT ACG CTG GAG-3 (Interactiva Virtual Laboratory) intro-
duces a flanking SacI cleavage site following the C-terminal stop codon.
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After digestion with BspH1 and SacI (New England Biolabs/Amersham
Biosciences), the fragment was introduced into a pET24d vector (kindly
provided by Gunter Stier, EMBL-Heidelberg, Germany) cleaved with SacI
and NcoI using the T4 DNA ligase Ready-To-Go kit (Amersham Bio-
sciences). The ligated vector was used to transform (30) Escherichia coli
DH5 and plated on Luria Bertani agar plates containing 30 g ml1
kanamycin, after which all transformants were collected for plasmid
preparation using Wizard Plus SV minipreps (Promega). The plasmids
were digested with BamH1 (New England Biolabs), whose cleavage site is
situated within the region of the pET24d cloning cassette supposedly
replaced by the TTR gene, and used for a second transformation (30) of
DH5 plated on 30 g ml1 kanamycin Luria Bertani agar plates. The
cloned sea bream TTR gene was sequenced using the DYEnamic ET
terminator kit (Amersham Biosciences) and an ABI 377 sequencer.
Protein Expression and Purification—Competent E. coli BL21 cells
were transformed (30) with the pET24d vector containing the sea bream
TTR construct and plated onto Luria Bertani agar plates containing 30
g ml1 kanamycin. One colony was selected and grown in Luria
Bertani with 30 g ml1 kanamycin at 30 °C to A600 nm  0.9, induced
with 0.2 mM isopropylthiogalactoside overnight, harvested by centrifu-
gation, and stored at 20 °C. Frozen cells were thawed and lysed in 10
ml of water that included 1 mg of lysozyme and MgCl2 for 10 min.
DNase I was added, followed by incubation for another 10 min and
centrifugation at 25,000  g for 20 min. The supernatant was loaded
onto a 10% preparative native PAGE (Model 491 Prep Cell; Bio-Rad)
equilibrated with 0.025 M Tris, pH 8.5, and 1.9 M glycine. Protein
fractions were analyzed by 20% SDS-PAGE; those containing pure sea
bream TTR were pooled, dialysed against 50 mM Tris, pH 7.5, concen-
trated to 5 mg ml1 (Centriprep; Amicon) and stored at 20 °C.
Crystallization and Data Collection—All crystals were grown using
the hanging-drop vapor-diffusion method (31). Drops with 8 l of a 5 mg
ml1 solution of sea bream TTR in 50 mM Tris, pH 7.5, were mixed with
2 l of well solution containing 40–44% polyethylene glycol 550
monomethyl ether (MME), 100 mM sodium citrate, pH 5.0, 100 mM
ammonium sulfate, and 26 mM nickel sulfate or cobalt chloride and
equilibrated at room temperature. Crystals 0.3  0.3  0.4 mm3 ap-
peared in 7 days and diffracted to 1.75 Å resolution. The crystals
belonged to the tetragonal space group P41 with one tetramer in the
asymmetric unit. Crystals of the two TTRhormone complexes diffracted
to 1.9 Å resolution. Both complexes were crystallized in a similar
fashion, i.e. the apo protein was incubated for 24 h at 4 °C with a
saturated solution of T3 or T4 in 50 mM Tris, pH 7.5, prior to the
crystallization trials. All data sets were collected at 100 K from single
crystals mounted in nylon loops (32), using synchrotron radiation at
beam line X11, European Molecular Biology Laboratory outstation,
German Synchrotron Research Centre, Hamburg, Germany. The data
were processed and scaled with the programs DENZO and SCALE-
PACK (33), after which the intensities were converted to structure
factors using the programs TRUNCATE and CAD from the CCP4
package (34). Data collection statistics are included in Table I.
Molecular Replacement and Structure Refinement—The structure of
the apo protein was solved by molecular replacement using the program
package CNS (35). A poly(alanine) model of the human transthyretin
tetramer was used as starting model (Protein Data Bank code 1F41,
Ref. 16) with the BC loops (residues 36–40), CD loops (residues 50–52),
-helices (residues 80–86), and FG loops (residues 98–104) removed.
The progress of refinement was followed by monitoring the Rfree value
from the start, with 10% of the reflections included in the test set (36).
After rigid body refinement, nearly all side chains could be manually
built into the first 2 Fo Fc map using the graphics software O (37). The
structure was refined by subsequent positional and temperature factor
refinement using CNS (35), REFMAC (38), and manual model building.
The hormone complexes were refined with REFMAC (38) by means of
difference Fourier techniques using the structure of the piscine apo
protein. The coordinates for T3 and T4 were derived from the Hetero-
compound Information Centre (39). The refined models comprise good
stereochemistry according to PROCHECK (40). Refinement statistics
are presented in Table I. Pictures were generated using the programs
MOLRAY (41), MOLSCRIPT (42), and RASTER3D (43).
Atomic coordinates and structure factors have been deposited in the
Research Collaboratory for Structural Bioinformatics (RCSB) with the
following accession codes: 1SN2 and RCSB021842 (apo fish TTR), 1SN0
and RCSB021841 (T4 complex), and 1SN5 and RCSB021843 (T3 complex).
RESULTS AND DISCUSSION
The Structure of Piscine Transthyretin—The structure of sea
bream TTR was solved using molecular replacement methods
with a truncated poly(alanine) model of human TTR (PDB
accession code 1F41, Ref. 16) as a search model. The quality of
the initial electron density map was excellent and allowed most
side chains of the fish TTR structure to be modeled. The four
monomers (A, B, C, and D) comprising the tetramer in the asym-
metric unit were refined independently of each other from the
start. The final model includes residues A10-A127, B10-B125,
C11-C125, D10-D123, 361 water molecules, and one sulfate ion
(Fig. 1). In some cases, additional electron density was observed
at the N- and C-terminal ends, but the quality did not allow
additional residues to be exclusively positioned. The side chains
of residues A-Gln-63, C-Glu-61, C-Gln-62, C-His-102, C-Ser-124,
D-Gln-62, and D-Gly-101 displayed weak electron density. Seven
residues were refined in two well defined conformations: A-Ser-
84, A-Asp-96, B-Ser-84, B-Thr-119, C-Asp-96, C-Thr-119, and
D-Thr-119. The 361 water molecules were positioned within
TABLE I
Data collection, refinement, and structural statistics for the sea bream TTR structures
Rmerge  h i  I ih  Ih  / hi Ih, where Ih is the mean intensity of the i observations of reflection h. R-factor    Fobs  Fcalc /  Fobs,
where Fobs and Fcalc are the observed and calculated structure factor amplitudes, respectively. Summation includes all reflections used in the
refinement. Rfree is evaluated for a randomly chosen subset comprising 10% of the diffraction data not included in the refinement. R.m.s.d. is the
root mean squared deviation from ideal values.
TTR (apo) TTRT3 TTRT4
Data collection
Space group P41 P41 P41
Cell dimensions (Å) a  b  58.50 a  b  58.28 a  b  58.46
c  140.71 c  138.90 c  140.12
Resolution 50–1.75 20–1.90 20–1.90
(Highest resolution shell) (Å) (1.81–1.75) (1.97–1.90) (1.97–1.90)
Number of observations 928494 305833 395502
Unique reflections 46104 (4416) 36032 (3581) 35498 (3244)
Completeness (%) 97.1 (92.2) 98.8 (96.6) 96.0 (89.7)
Rmerge (%) 4.7 (45.1) 5.4 (43.4) 4.7 (44.6)
Refinement
Resolution range used in refinement (Å) 20–1.75 20–1.9 20–1.9
Reflections in working set 39742 31100 30446
Reflections in test set 4439 3405 3336
R-factor working set (%) 17.5 17.3 17.9
Rfree test set (%) 21.0 21.1 21.6
Mean temperature factor (Å2) 21.6 14.4 14.6
R.m.s.d. bond lengths (Å) 0.008 0.010 0.009
R.m.s.d. bond angles ( °) 1.30 1.46 1.40
Torsion angles period 1 ( °) 3.96 4.01 4.04
Torsion angles period 3 ( °) 18.39 18.30 18.30
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proper hydrogen-bonding distances (less than 3.4 Å) from the
protein with refined temperature factors less than 60 Å2.
The four monomers in sea bream TTR are very similar. Root
mean square deviations comparing the main chain C atoms of
residues 12–123 among all monomers varies from 0.27 Å (com-
paring monomers A and B) to 0.51 Å (comparing monomers A
and C). The sulfate ion bridges the main chain carbonyl oxygen
of His-102 in the FG loop of monomer A and the O atom of
Ser-123 to the main chain nitrogen atom of Ser-124 at the
C-terminal end of monomer A. This sulfate ion is also part of
the crystal-packing interface forming a salt link to the side
chain of Arg-103 in a symmetry-related copy of monomer B
(B). All sulfate atoms are well defined with B-factors of 34–36
Å2 and restrict the mobility at the C-terminal end of monomer
A, which could be modeled to the last residue, A-Glu-127.
The N terminus of piscine, avian, and reptilian TTR has
three additional hydrophilic amino acids, DKH, compared
with the eutherian proteins. A chimeric molecule generated
from crocodile TTR, in which the N-terminal end was re-
placed by that from frog, was shown to differ in both the
specificity and affinity of T4 and T3 binding. Therefore, it
appears that the amino-terminal regions of TTR could influ-
ence its thyroid binding properties (13). Interestingly, in the
sea bream structure, electron density runs through the cen-
ter of the hormone-binding channel visible at lower contour
levels of the electron density maps (Fig. 2). We could not
identify the source of this density, but water molecules seem
unlikely because the density does not connect to potential
hydrogen-bonding partners on the protein. Two possibilities
are that the electron density corresponds to residues at the
N-terminal end of the protein or to polyethylene glycol mol-
ecules present in the crystallization medium.
While this work was in revision, a structure of sea bream
TTR in a different crystal form was independently reported by
Folli et al. (44). We find their structure virtually identical to
ours with the exception of the positions of the FG loops. There
have been controversies about the correct amino acid at posi-
tion 103 (5, 7). By sequencing the clone, we would like to correct
the original data published in Ref. 7 and confirm that the
correct amino acid at position 103 should be an arginine. It
should, however, be noted that the structure deposited by Folli
et al. is reported to have a glycine at this position.
Comparison of Piscine TTR with Other Species—Crystal
structures of TTR are available from three other species; hu-
man (16), chicken (20), and rat (21). Overall, the structure of
sea bream TTR is very similar to those of rat and human with
root mean square deviations of 0.62 and 0.71 Å, respectively,
when superimposed on residues 12–98 and 104–123. Chicken
TTR deviates significantly from fish, human, and rat in the
conformation of the -helix and succeeding EF loop (residues
75–88), and its root mean square deviation to sea bream TTR
is 1.3 Å. These differences are most likely caused by a sulfate
ion located in the -helix region of the chicken structure, a
different position compared with the sulfate found in sea bream
TTR, that binds to the FG-loop (residues His-102 and Arg-103)
and C-terminal (residues Ser-123 and Ser-124).
Water molecules W1-W36 play a significant role in stabiliz-
ing the monomeric (W1-W12), dimeric (W13-W20), and tet-
rameric (W21-W36) forms of the human protein (16). These
water molecules are not strictly conserved in sea bream TTR,
but all the corresponding molecules were numbered equivalent
to human TTR (W1-W36 in monomers A and B and V1-V36 in
monomers C and D) (Fig. 1). One novel water molecule is
situated at the edge-strand region of each monomer, which is
the only area with significant structural differences between
human and piscine TTR. When comparing the two structures,
the dissimilarity is already visible at the end of -strand B,
even more so in -strand C, and most apparent in what corre-
FIG. 1. C trace of sea bream TTR (cyan) superimposed over
the human protein (dashed black lines; Protein Data Bank code
1F41). Water molecules unique for sea bream TTR are pink, those
present in human TTR but absent in the fish structure are blue, and
waters found in both structures are green. The sulfate group present in
sea bream TTR is drawn as ball-and-sticks.
FIG. 2. The 2 Fo  Fc electron density map at the thyroid hor-
mone-binding channel in sea bream apo TTR. Contours are drawn at
a level of 0.6, where  is the root mean square density throughout the
unit cell. The sea bream complex structures are drawn with carbons in
yellow, nitrogens in blue, oxygens in red, and sulfurs in green.
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sponds to -strand D in human TTR. Sea bream TTR lacks a
proper -strand D and instead forms an extended loop region
stabilized by a novel water molecule W39 (W40, W139, and
W140 in the B, C, and D monomers, respectively). This water
molecule bridges the D loop to -strand A, forming hydrogen
bonds to the main chain nitrogen and oxygen atoms of Ile-55
and the main chain nitrogen atom of Val-14 (Fig. 3, A and B).
The piscine edge-strand conformation is reminiscent of chicken
TTR, which also lacks -strand D, whereas this area in the rat
homologue is more similar to the human protein.
An analysis of human mutations associated with familial amy-
loidotic polyneuropathy compared with a multiple sequence
alignment of the TTR sequences from 20 different species shows
that only six familial amyloidotic polyneuropathy mutations oc-
cur as natural amino acids in other species (4). Leu-68 is found in
eight species, Thr-45 in African clawed frog, Asp-42 and Ser-45 in
bullfrog, and Leu-30 and Ser-84 in fish. The positions of both
Leu-30 and Ser-84 are well defined in the electron density of sea
bream TTR, but their structural significance is difficult to inter-
pret because they are situated in regions with additional side
chain substitutions compared with the human protein.
Hormone Binding to Sea Bream TTR—We have previously
shown that the binding properties of T3 and T4 for purified
recombinant sea bream TTR are similar to those for the endog-
enous serum protein in sea bream (4). The x-ray crystal struc-
tures of human TTR in complex with T4 provide the first
detailed description of a thyroid hormone binding to TTR (17,
45). These studies show that the two TTR hormone-binding
sites, situated between monomers A, C and B, D, respectively,
can be divided in three sections: an inner and outer cavity
comprising three symmetry-related pairs of halogen-binding
pockets, HBP1 (HBP1), HBP2 (HBP2), and HBP3 (HBP3).
The 2-fold symmetry axis of the TTR homotetramer runs in the
direction of the hormone-binding channel and coincides with the
2-fold crystallographic symmetry axis in crystals with the P21212
space group. However, most TTR ligands lack 2-fold symmetry,
and subsequently the x-ray structures of human TTR complexes
in the P21212 space group have to be refined with the ligand
positioned in two symmetry-related conformations with 50% oc-
cupancy. This complicates the electron density map interpreta-
tion and reduces the accuracy of the model. Recently, aligned
thyroxine molecules were presented from structural studies of
human and rat TTR crystals with tetramers rather than dimers
in the asymmetric unit (46, 47). Interestingly, these structures
show that ligand binding imposes subtle structural differences in
the AC dimer compared with the BD dimer that is selected for in
the crystal packing of the TTR tetramers. A multitude of struc-
tural data about TTRligand complexes is available (17, 45, 47–
53). Combined, these studies show a complicated picture of TTR-
ligand interactions where the same ligand can have more than
one binding site in the hormone-binding channel.
T4 comprises four iodines: I3 and I5 at the tyrosyl ring and I3
and I5 at the phenolic ring. In the human TTRT4 complex, the
I3 and I5 iodines are situated at the outer HBP1 site, whereas I3
and I5 are situated at the innermost HBP2 and HBP3 sites (17,
45). The polar amino group interacts with the charged residues
Lys-15 and Glu-54 at the entrance of the channel. In the struc-
ture of T4 in complex with rat TTR, T4 occupies two positions in
the AC and BD-binding sites of the tetramer. One position is
similar to T4 in the human protein where the phenolic iodines
occupy the HBP2/HBP3 pocket; in the second position the phe-
nolic iodines occupy the HBP3/HBP3 pocket (47). The structure
of human TTR in complex with T3 is not known. We have made
several attempts to obtain this structure but so far without suc-
cess. We have collected high resolution diffraction data of both
crystals soaked in T3 and of co-crystals obtained at high concen-
tration of T3. In both cases, the determined protein structures
represented the apo form of the protein. We did not detect any
binding of T3 to human recombinant TTR in the dot-blot analysis,
which shows strong binding of T3 to sea bream TTR (4). This
suggests that binding of T3 to human recombinant TTR is weaker
than to the serum TTR protein.
The sea bream TTR complexes with T3 and T4 were each
studied at 1.90 Å resolution. Generally, hormone binding did not
induce any major structural changes and strand D maintained
its extended loop conformation. The position of the three and four
iodines in T3 and T4, respectively, could be clearly identified from
omit maps (Fig. 4). However, the thyronine rings and alanyl
moiety are less well defined in both complex structures. As in the
FIG. 3. The conformation of -strand D in monomer A. A, hu-
man TTR. B, sea bream TTR. -strand D, defined by three hydrogen
bonds from residues Gly-53 and Leu-55 to residues Val-16 and -14
situated on -strand A, are indicated as black dashed lines in the
human structure. The novel water molecule W39 in sea bream is pink;
waters W9 and W10 present in both structures are green.
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previously described human and rat TTR tetramers, the electron
density maps display one unique binding mode of the T4 hor-
mone, suggesting that sea bream TTR tetramers are aligned
within the crystals. T4 binds similarly to sea bream TTR com-
pared with human and rat TTR. However, the hormone molecule
does not reach as deeply into the binding pocket and is situated
1 Å closer to the entrance (Fig. 4B). This binding positioned the
I3 and I5 atoms symmetrically at the halogen-binding pockets
FIG. 4. T4 and T3 binding in monomer A of sea bream TTR (A) of the sea bream TTRT4 complex. B, T4 binding to human TTR (light gray),
rat TTR (blue), and sea bream TTR (dark blue). All structures are superimposed on residues A12-A98 and A104-A123. The T4 molecule does
not reach as deep into the hydrophobic channel of sea bream TTR as it does in human and rat TTR; thus, none of the four iodines binds to the
HBP3. C, the sea bream TTRT3 complex. Three strong electron density features correspond to two equivalent positions of the T3 ligand. The
fourth and weaker electron density feature shows that a smaller fraction of the T3 molecules is position equivalent to the T4 molecule. This
density is, however, not present in monomer B of sea bream TTR. D, comparison of T4 (dark blue) and T3 (red) binding to sea bream TTR. The
sea bream complex structures in panels A and C are colored as in Fig. 2. Omit Fo  Fc maps are contoured at 6 over the hormone-binding site.
X-ray Structure of Sea Bream Transthyretin 26415










HBP2 and HBP2. Furthermore, the HBP3 and HBP3 sites do
not bind iodine in the piscine TTRT4 complex.
In the TTRT3 complex, four strong electron density features
were observed in the AC-binding site, one of which is situated
at the position of the hydroxyl group, O4, in T4. This site is now
occupied to a large extent by the third iodine, I3, in T3 (Fig.
4C). In this novel T3 conformation, the O4 group is instead
close to the main chain atoms of Leu-109 and -110 (distances
are 3.0–3.2 Å). This position cannot be adopted by T4 because
it leaves no room for the additional I5 atom (Fig. 4D). The
electron density also shows that a small fraction (20%) of T3
is positioned identically to T4. At the BD-binding site, electron
density features for only three T3 iodines were found. Thus the
T4-binding position is not occupied by T3 in the BD-binding
site. As in the piscine TTRT4 complex, there was no iodine in
the HBP3-binding site in the TTRT3 complex. Further struc-
tural studies are needed to elucidate whether HBP3 of piscine
TTR comprises a halogen-binding site or not.
Superimposing the sea bream TTRT3 structure with all
available human TTR complex structures shows that the novel
binding of T3 to piscine TTR has a small resemblance to the
binding of pentabromphenol and 2,4,6-tribromphenol to human
TTR (53). Both bromphenols bind in the so-called “reversed”
mode with their hydroxyl group directed toward the opening of
the channel. One halogen of each ligand occupies the same
position as the hydroxyl group in the human TTRT4 complex
and the phenolic iodine I3 in the sea bream TTRT3 complex.
With the exception of the number of water molecules within
the apo proteins, the hormone-binding channels of sea bream and
human TTR appear very similar. The only amino acid difference
within the channel is the conservative substitution of Thr-117 in
sea bream to Ser in human TTR, situated 4 Å away from the
hormone molecule. However, the shape of the hormone-binding
channel of sea bream and human TTR is different, which ex-
plains the discrepancies in T3- and T4 binding affinities of the two
species. The areas of the cavity enclosing the inner phenolic and
the outer tyrosyl rings of the hormone are clearly narrower in fish
TTR. This is evident upon comparing the distance between two
symmetry-related residues at position 108, which is 11.2 Å in sea
bream TTR and 12.0Å in human TTR, and between the C atoms
of two symmetry-related Lys-15 residues, 12.5–12.6 Å in fish
TTR compared with 13.5–13.8 Å in human TTR. In addition, the
sea bream TTR hormone-binding channel is wider at its en-
trance, right at the binding site for the alanyl group of the
hormone. At the entrance, the distance between two C atoms of
Glu-54 is 18.9–19.0 Å in sea bream TTR compared with 17.5–
17.6 Å in the human protein. These dissimilarities are due in part
to a number of amino acid substitutions in the hydrophobic core
of fish TTR compared with the human protein, including Ile-16
for Val, Leu-30 for Val, Ile-44 for Phe, Ile-55 for Leu, Ile-59 for
Thr, Phe-73 for Ile, Leu-109 for Ala. Furthermore, different side
chain rotamers of Val-14 and Leu-58 affect the position of the
otherwise conserved residues involved in hormone binding. The
significantly wider entrance of the hormone-binding channel in
combination with its narrower inner and outer cavity provides a
structural explanation for the different binding affinities of T3
and T4 to avian and piscine TTR compared with human TTR. The
inner phenolic ring of the T3 molecule has only one iodine and is
therefore smaller than the phenolic ring of T4 and in its novel
position in the outer tyrosyl ring is parallel to the Lys-15 side
chains in a conformation optimal for the restricted channel of sea
bream TTR. Avian TTR, which also has higher affinity for T3
than T4 (10), displays a similar overall shape as sea bream TTR.
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